Description
Demonstrating Drug Value through Late-Phase Data Generation 2011 is a conference that brings together executives from Pharmaceutical & Biotech companies that are involved in Pharmacovigilance, Data Management, Regulatory Affairs, Epidemiology, Clinical Development & Operations and Drug Safety.
The event covers topics such as product value and real-life data, technologies, phase 4 protocol design and trial implementation, drug evaluation, KOLs and investigators, safety, regulatory, clinical, Marketing, methodologies and real-life case studies in the field.
